Why UiPath stock rocketed 29% higher in 2025

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath (NYSE: PATH) defied critics in ...

Should You Forget Palantir and Buy These 2 Tech Stocks Instead?

However, Palantir's huge gains have left the stock at a huge valuation; it's trading at a forward price-to-sales (P/S) ...
Investor's Business Daily on MSN

UiPath sees composite rating move up to 96

UiPath PATH saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental Portfolio ...
KMWorld

UiPath and Talkdesk collaborate to transform customer experience journeys

Model Context Protocol-based agentic integration allows for faster, more accurate access and usage of data and information to reduce errors and elevate productivity ...

UiPath (PATH) Valuation Check After CEO Share Sales And S&P MidCap 400 Inclusion

UiPath (PATH) has been in focus after CEO Daniel Dines disclosed share sales under a pre arranged trading plan at the same time the company entered the S&P MidCap 400, which drew extra attention to ...
diginomica

Evergen and UiPath show how agentic AI tests process discipline in regulated industries

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Is UiPath (PATH) Pricing Look Interesting After Recent Share Price Weakness

If you are wondering whether UiPath's share price reflects its true worth or leaves some room on the table, you are in the right place. UiPath's stock closed at US$15.88, with a 5.7% decline over the ...